MED20 antibody (AA 1-212) (Cy3)
Quick Overview for MED20 antibody (AA 1-212) (Cy3) (ABIN8008606)
Target
See all MED20 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-212
-
Purpose
- Anti-TRFP/MED20 Antibody Cy3 Conjugated
-
Specificity
- No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human TRFP / MED20 recombinant protein (Position: M1-R212).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- MED20 (Mediator Complex Subunit 20 (MED20))
-
Alternative Name
- MED20
-
Background
-
Background: MED20 is a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. A mutation in this gene has been associated with a novel infantile-onset neurodegenerative movement disorder.
Gene Full Name: mediator complex subunit 20
-
Gene ID
- 9477
-
UniProt
- Q9H944
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-